Clinical and biochemical characteristics and outcomes of suspected COVID-19 hospitalized patients: RT-PCR swab positive and negative comparison.
COVID-19
Clinical characteristics
Negative RT-PCR
Suspected COVID-19
Journal
Journal of infection and public health
ISSN: 1876-035X
Titre abrégé: J Infect Public Health
Pays: England
ID NLM: 101487384
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
19
08
2021
revised:
16
09
2021
accepted:
19
09
2021
pubmed:
9
10
2021
medline:
11
11
2021
entrez:
8
10
2021
Statut:
ppublish
Résumé
COVID-19 is diagnosed using RT-PCR assays of samples from nasal and oropharyngeal swabs. People with negative RT-PCR often presented with clinical manifestations of COVID-19. The data on such patients are lacking. The present study aims to characterize the patients who were suspected COVID-19 cases and tested negative in RT-PCR compared to patients who had been tested RT-PCR positive. This is a retrospective, observational study of adult suspected and confirmed patients of COVID-19 admitted to King Saud University Medical City, Riyadh, Saudi Arabia, from 1st March 2020 until 30th November 2020. Laboratory confirmation is done through nasal/pharyngeal swab specimens, tested positive in RT-PCR assay. Patients with initial negative RT-PCR test results were assessed again within 48-72 h to avoid false-negative results. Patient data were extracted from the electronic medical files of each included patient using a predesigned case report form. The study included 488 (80.93%) patients with RT-PCR swab results positive, and 115 (19.07%) patients who were negative. Respiratory rate and diastolic blood pressure were higher among the swab-positive cases. More number of swab-negative patients had comorbidities such as coronary heart disease, chronic kidney disease, and carcinoma. Fever, cough, and shortness of breath were reported higher among the swab-positive cases. ALT and AST, and LDH levels were found higher among RT-PCR-positive patients. Serum creatinine, blood urea nitrogen and troponin were more elevated in RT-PCR-negative patients. Antibiotics, anticoagulants, and corticosteroids were used more by swab-positive patients. Significantly higher number of RT-PCR-positive patients required proning, high-flow nasal cannula, non-invasive mechanical ventilation, and invasive mechanical ventilation. Acute cardiac ischemia and death were found to be similar among the patients. However, deaths occurred significantly earlier among the swab-positive cases when compared to the swab-negative group. Distinctive symptoms and markers of COVID-19 are more frequent among patients who had RT-PCR-positive results.
Sections du résumé
BACKGROUND
BACKGROUND
COVID-19 is diagnosed using RT-PCR assays of samples from nasal and oropharyngeal swabs. People with negative RT-PCR often presented with clinical manifestations of COVID-19. The data on such patients are lacking. The present study aims to characterize the patients who were suspected COVID-19 cases and tested negative in RT-PCR compared to patients who had been tested RT-PCR positive.
METHODS
METHODS
This is a retrospective, observational study of adult suspected and confirmed patients of COVID-19 admitted to King Saud University Medical City, Riyadh, Saudi Arabia, from 1st March 2020 until 30th November 2020. Laboratory confirmation is done through nasal/pharyngeal swab specimens, tested positive in RT-PCR assay. Patients with initial negative RT-PCR test results were assessed again within 48-72 h to avoid false-negative results. Patient data were extracted from the electronic medical files of each included patient using a predesigned case report form.
RESULTS
RESULTS
The study included 488 (80.93%) patients with RT-PCR swab results positive, and 115 (19.07%) patients who were negative. Respiratory rate and diastolic blood pressure were higher among the swab-positive cases. More number of swab-negative patients had comorbidities such as coronary heart disease, chronic kidney disease, and carcinoma. Fever, cough, and shortness of breath were reported higher among the swab-positive cases. ALT and AST, and LDH levels were found higher among RT-PCR-positive patients. Serum creatinine, blood urea nitrogen and troponin were more elevated in RT-PCR-negative patients. Antibiotics, anticoagulants, and corticosteroids were used more by swab-positive patients. Significantly higher number of RT-PCR-positive patients required proning, high-flow nasal cannula, non-invasive mechanical ventilation, and invasive mechanical ventilation. Acute cardiac ischemia and death were found to be similar among the patients. However, deaths occurred significantly earlier among the swab-positive cases when compared to the swab-negative group.
CONCLUSION
CONCLUSIONS
Distinctive symptoms and markers of COVID-19 are more frequent among patients who had RT-PCR-positive results.
Identifiants
pubmed: 34624717
pii: S1876-0341(21)00275-6
doi: 10.1016/j.jiph.2021.09.014
pmc: PMC8457915
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1623-1629Informations de copyright
Copyright © 2021. Published by Elsevier Ltd.
Références
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
Front Immunol. 2020 Jul 10;11:1708
pubmed: 32754163
Sci Rep. 2021 Apr 20;11(1):8562
pubmed: 33879826
Nurse Pract. 2021 Jan 1;46(1):21-26
pubmed: 33332825
J Infect Public Health. 2020 Nov;13(11):1639-1644
pubmed: 33004305
PLoS One. 2020 Dec 10;15(12):e0242958
pubmed: 33301459
Cleve Clin J Med. 2020 Jul 31;87(8):461-468
pubmed: 32409435
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):529-534
pubmed: 33668003
J Epidemiol Glob Health. 2020 Sep;10(3):214-221
pubmed: 32954712
Infect Control Hosp Epidemiol. 2021 Mar;42(3):372-373
pubmed: 32456750
J Clin Lab Anal. 2020 Oct;34(10):e23618
pubmed: 33078400
Sci Rep. 2021 Jan 28;11(1):2455
pubmed: 33510247
EBioMedicine. 2021 May;67:103356
pubmed: 33910120
PLoS One. 2020 Dec 7;15(12):e0243191
pubmed: 33284825
Clin Chim Acta. 2020 Oct;509:249-251
pubmed: 32579952
BMJ Open. 2017 Jun 1;7(5):e014294
pubmed: 28576889
Am J Hematol. 2020 Jun;95(6):E131-E134
pubmed: 32129508
Ann Hematol. 2021 Mar;100(3):675-689
pubmed: 33523290
BMC Infect Dis. 2021 Mar 11;21(1):256
pubmed: 33706699